Intranasal H5N1 Vaccines, Adjuvanted with Chitosan Derivatives, Protect Ferrets against Highly Pathogenic Influenza Intranasal and Intratracheal Challenge

• Alex J. Mann ,

  * E-mail: a.mann@retroscreen.com

  Affiliation Retroscreen Virology, London, United Kingdom

  ⨯
• Nicolas Noulin,

  Affiliation Retroscreen Virology, London, United Kingdom

  ⨯
• Andrew Catchpole,

  Affiliation Retroscreen Virology, London, United Kingdom

  ⨯
• Koert J. Stittelaar,

  Affiliation Viroclinics Biosciences BV, Rotterdam, Netherlands

  ⨯
• Leon de Waal,

  Affiliation Viroclinics Biosciences BV, Rotterdam, Netherlands

  ⨯
• Edwin J. B. Veldhuis Kroeze,

  Affiliation Viroclinics Biosciences BV, Rotterdam, Netherlands

  ⨯
• Michael Hinchcliffe,

  Current address: Paracelsis Ltd, Nottingham, United Kingdom

  Affiliation Archimedes Development Limited, Nottingham, United Kingdom

  ⨯
• Alan Smith,

  Affiliation Archimedes Development Limited, Nottingham, United Kingdom

  ⨯
• Emanuele Montomoli,

  Affiliations University of Siena, Siena, Italy, VisMederi LifeSciences, srl, Siena, Italy

  ⨯
• Simona Piccirella,

  Affiliation VisMederi LifeSciences, srl, Siena, Italy

  ⨯
• Albert D. M. E. Osterhaus,

  Affiliations Viroclinics Biosciences BV, Rotterdam, Netherlands, Department of Viroscience, Erasmus MC, Rotterdam, Netherlands

  ⨯
• Alastair Knight,

  Affiliation Evicom, Teddington, United Kingdom

  ⨯
• John S. Oxford,

  Affiliation Retroscreen Virology, London, United Kingdom

  ⨯
• Giulia Lapini,

  Affiliation University of Siena, Siena, Italy

  ⨯
• Rebecca Cox,

  Affiliations Department of Clinical Science, University of Bergen, Bergen, Norway, Department of Research and Development, Haukeland University Hospital, Bergen, Norway

  ⨯
•  [ ... ],
• Rob Lambkin-Williams

  Affiliation Retroscreen Virology, London, United Kingdom

  ⨯
• [ view all ]
• [ view less ]